CannabisNewsBreaks

WednesdayMay 15, 2024 3:46 pm

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Journeys Toward Creation of One-of-a-Kind Destination

Golden Triangle Ventures (OTC: GTVH) is a multifaceted consulting company that operates as a parent business pursuing ventures in the health, entertainment and technology sectors. GTVH and its entertainment division, Lavish Entertainment, are working with Cayenne Consulting on the strategic development of Destino Ranch. “Destino Ranch aims to redefine luxury entertainment and hospitality experiences. Set amid the breathtaking landscapes of the Mojave Desert, Destino Ranch will offer a unique blend of world-class entertainment, luxurious accommodations and immersive experiences. The destination location is designed to be an outdoor music and festival venue, immersive art installation and tourist attraction,” a recent article…

Continue Reading

TuesdayMay 14, 2024 3:34 pm

CannabisNewsBreaks – Zoned Properties Inc. (ZDPY) Releases Q1 2024 Financial Results Showing 22% Revenue Growth

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, including legalized cannabis, released its financial results for Q1 2024, the period ended March 31; the company also noted recent business highlights. According to the report, financial highlights include revenues totaling $837,052 for the quarter ended March 31, 2024, compared to $688,024 million revenues for the same quarter 2023, representing an increase of 22%; net income of $96,473, or $0.01 per fully diluted share, as compared to a net loss of $309,648, or ($0.03) per fully diluted share, for the same quarter in 2023, representing…

Continue Reading

TuesdayMay 14, 2024 2:31 pm

CannabisNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Releases Q3 202 Financial Report

Astrotech (NASDAQ: ASTC), an innovative science and technology company, is reporting its financial results for the third quarter of fiscal year 2024, for the period ended March 31, 2024. Highlights of the report include the company’s strong consolidated balance sheet showing $34.7 million in cash and liquid investments; revenue for the year-to-date coming in at $1.6 million; year-to-date gross margin increased to 45% from 37% through the third quarter of fiscal year 2024; the company’s subsidiary, 1st Detect, accepting orders for the TRACER 1000 Narcotics Trace Detector (“NTD”); the TRACER 1000 being listed in the U.S. General Services Administration (“GSA”) IT…

Continue Reading

MondayMay 13, 2024 3:26 pm

CannabisNewsBreaks – Zoned Properties Inc. (ZDPY) Bridging Gaps in Cannabis Space with Requisite Real Estate and Consultation Services

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, acquires value-add real estate within the regulated U.S. cannabis industry with selective development innovation and aspirations to spearhead direct-to-consumer real estate leased to best-in-class cannabis retailers. “The aptly named company has a deep understanding of all the hurdles and potholes to opening compliant cannabis operations and is now redefining the approach to commercial real estate investment through its standardized investment process backed by its proprietary property technology. In its effort, the company has developed a national ecosystem of real estate services to support its real…

Continue Reading

MondayMay 13, 2024 1:23 pm

CannabisNewsBreaks – CannaCon Names CannabisNewsWire, IBN as Media Partners for Upcoming 2024 Events

CannaCon, a global business-to-business (“B2B”) venue for cannabis businesses, marijuana entrepreneurs, investors and community partners, has selected CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of more than 60 brands powered by IBN, as the Official NewsWire for its upcoming CannaCon West Albuquerque; the event is slated for May 17–18, 2024. In addition, CannabisNewsWire and IBN will partner with CannaCon as official media partners for several upcoming events, including Midwest conferences scheduled on Aug. 16–17, 2024, in Albuquerque and on Oct. 3–4, 2024, in Cleveland. According to the announcement, IBN and CNW will use their comprehensive portfolio of communications…

Continue Reading

FridayMay 10, 2024 2:58 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (SFWJ) Sets Stage for Future Expansion

Software Effective Solutions (OTC: SFWJ) is among companies working to ensure sustainable agricultural practices. A recent article highlights the company’s majority-controlled, Colombia-based subsidiary Eko2o S.A.S.’s entry into a major multiyear contract with Danziger Colombia, the world’s largest producer of flower seedlings. The contract represents a smart financial move and the commitment of both companies to sustainable, innovative agriculture practices. “We are thrilled to embark on this initial phase with Danziger,” Juan Ricardo Velez, Eko2o CEO, was quoted as saying. “This partnership not only represents a significant milestone for our company but also sets the stage for future expansion. We eagerly…

Continue Reading

ThursdayMay 09, 2024 3:39 pm

CannabisNewsBreaks – Astrotech Corporation (NASDAQ: ASTC) Filling Void in Hemp and Cannabis Market

Astrotech (NASDAQ: ASTC), a science and technology development and commercialization company, and its wholly owned subsidiary, AgLAB Inc., have developed a mass spectrometer designed for use in the hemp and cannabis market. “During the process of converting cannabis biomass into distillate, valuable cannabinoids are typically lost, resulting in reduced profits. AgLAB’s Maximum Value Processing (‘MVP’) method uses the powerful AgLAB-1000-D2 mass spectrometer to test and to accurately configure the distillation system for optimal efficiency. The AgLAB MVP mass spectrometer and its rugged design are built to withstand the demands of the factory floor. The AgLAB-1000-D2 model offers real-time potency tests…

Continue Reading

WednesdayMay 08, 2024 2:16 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing of Human Pilot Study No. 2, GLP-1-H24-2

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its second human pilot study, GLP-1-H24-2, is underway and the first dosing visit for all nine study participants has concluded. The three-arm, crossover study will compare three 7 mg semaglutide dose formulations: A positive control Rybelsus(R) swallowed tablet (already dosed); DehydraTECH-semaglutide swallowed capsules; and, for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. According to the announcement, the second DehydraTECH study arm will use a Rybelsus(R) composition processed with DehydraTECH that is compliant with the U.S. Food and Drug Administration’s Inactive Ingredient Database…

Continue Reading

MondayMay 06, 2024 3:15 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches New Research Program to Evaluate DehydraTECH-GLP-1 Drugs

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, related to its mode of action and performance. According to the announcement, the research will be conducted in partnership with the National Research Council of Canada (“NRC”). “We are excited about our partnership with the NRC for the mode of action molecular characterization of DehydraTECH-GLP-1 drugs. This work program could potentially provide data to assist Lexaria’s efforts in partnering with the pharmaceutical industry for the most rapid…

Continue Reading

WednesdayMay 01, 2024 3:50 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Responds to Announcement Rescheduling of Marijuana by DEA

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), a holding company focused in the cannabis and agricultural technology sectors, released an official reaction to the “historic milestone” in the cannabis industry as the U.S. Drug Enforcement Administration (“DEA”) moves to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act (“CSA:). The reclassification was fueled by a recommendation from the U.S. Department of Health and Human Services and represents a notable change in U.S. drug policy. According to the announcement from MedCana, cannabis has been unjustly categorized as a Schedule I substance alongside heroin and LSD for…

Continue Reading